Perceived stigma among patients receiving antiretroviral treatment

A prospective randomised trial comparing an m-DOT strategy with standard-of- care in Kenya

Dados Bibliográficos

ID2177592
AutoresSusan Kaai (0000-0001-7516-3734, University of Waterloo), Sandra Bullock (0000-0002-4913-5745, University of Waterloo), Avina Sarna (0000-0003-1713-426X), Matthew Chersich (0000-0002-4320-9168, University of the Witwatersrand), Luchter (0000-0001-5235-5629, Ghent University), Stanley Luchter, Scott Geibel (0000-0001-9969-8776), Paul Munyao (0000-0002-7779-5310, ICAP, Kenya), Kishorchandra Mandaliya (Coastal Oceans Research and Development in the Indian Ocean), Marleen Temmerman (0000-0003-2069-8752, Ghent University Hospital), Naomi Rutenberg
Ano2010
Volume7
Fascículo2
Páginas62-70
Data de publicação2010-08-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoSAHARA-J Journal of Social Aspects of HIV/AIDS (JOURNAL)
Identificadores do periódicoISSN: 1729-0376 • E-ISSN: 1813-4424
EditoraInforma UK Limited (PUBLISHER • GB)
DOI10.1080/17290376.2010.9724958
PMID21409296
OpenAlexW1978242644
IdiomaEN
Citações recebidas7
Referências citadas62

HIV and AIDS remain highly stigmatised. Modified directly observed therapy (m-DOT) supports antiretroviral treatment (ART) adherence but little is known about its association with perceived stigma in resource-constrained settings. In 2003, 234 HIV-infected adults enrolled in a two-arm randomised trial comparing a health centre-based m-DOT strategy with standard self-administration of ART. Data on perceived stigma were collected using Berger's HIV stigma scale prior to starting ART and after 12 months. This was a secondary analysis to examine whether perceived stigma was related to treatment delivery. Perceived stigma scores declined after 12 months of treatment from a mean of 44.9 (sd=7.6) to a mean of 41.4 (sd=7.7), (t=6.14, P<0.001). No differences were found between the mean scores of participants in both study arms. Also, no difference in scores was detected using GLM, controlling for socio-demographic characteristics and baseline scores. Findings indicate that a well managed clinic-based m-DOT does not increase perceived HIV-related stigma

Antiretroviral therapy · Antiretroviral treatment · Family medicine · Psychiatry · Social stigma · Viral load · Clinical Psychology · Demography · HIV Research and Treatment · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine